Cargando…
A CD8(+) NK cell transcriptomic signature associated with clinical outcome in relapsing remitting multiple sclerosis
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS) with the majority of cases characterised by relapsing/remitting (RRMS) attacks of neurologic dysfunction followed by variable resolution. Improving clinical outcomes in RRMS requires both a better un...
Autores principales: | McKinney, Eoin F., Cuthbertson, Iona, Harris, Kristina M., Smilek, Dawn E., Connor, Christopher, Manferrari, Giulia, Carr, Edward J., Zamvil, Scott S., Smith, Kenneth G. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840761/ https://www.ncbi.nlm.nih.gov/pubmed/33504809 http://dx.doi.org/10.1038/s41467-020-20594-2 |
Ejemplares similares
-
Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis
por: Gilmore, Wendy, et al.
Publicado: (2020) -
Thalamic–hippocampal–prefrontal disruption in relapsing–remitting multiple sclerosis
por: Kern, Kyle C., et al.
Publicado: (2014) -
Postural Control in Relapsing-Remitting Multiple Sclerosis
por: Cusin, Flavia Salvaterra, et al.
Publicado: (2022) -
Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
por: Tenorio-Laranga, Jofre, et al.
Publicado: (2010) -
Varicella Zoster Virus and Relapsing Remitting Multiple Sclerosis
por: Sotelo, Julio, et al.
Publicado: (2011)